NYMC Faculty Publications
Pralatrexate-Based Therapy Induced Response in an Adolescent with Refractory Hepatosplenic T-Cell Lymphoma
DOI
10.1002/pbc.28460
Journal Title
Pediatric Blood & Cancer
First Page
28460
Last Page
28460
Document Type
Case Report
Publication Date
11-2020
Department
Pediatrics
Second Department
Health Behavior and Community Health
Keywords
Adolescent, Aminopterin, Antineoplastic Combined Chemotherapy Protocols, Cyclophosphamide, Doxorubicin, Drug Resistance, Neoplasm, Female, Humans, Liver Neoplasms, Lymphoma, T-Cell, Prednisone, Prognosis, Splenic Neoplasms
Disciplines
Medicine and Health Sciences | Oncology | Pediatrics
Recommended Citation
Dhir, A., Hill, B., Waite, E. S., Cairo, M. S., & Xavier, A. C. (2020). Pralatrexate-Based Therapy Induced Response in an Adolescent with Refractory Hepatosplenic T-Cell Lymphoma. Pediatric Blood & Cancer, 67 (11), 28460-28460. https://doi.org/10.1002/pbc.28460
